drug
Atrial Fibrillation
Preclinicalupdated 5mo agoby Inomagen Therapeutics Inc
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 8- tagAtrial Fibrillation13 co-mentions · 6 sources
- tagHematology8 co-mentions · 1 sources
- tagCardiology5 co-mentions · 2 sources
- tagHeart Failure3 co-mentions · 1 sources
- companyBaylor College of Medicine2 co-mentions · 2 sources
- tagAdCom2 co-mentions · 1 sources
- tag510(k) Clearance2 co-mentions · 1 sources
- companyAlfred Health Victoria1 co-mentions · 1 sources
indications
indications
Atrial Fibrillation
all catalysts(0)
nothing on the calendar yet
Trials studying Atrial Fibrillation
- N/APULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study
- N/AFrom the Emergency Department Directly to Ablation of Atrial Fibrillation Study
- N/AMobile Health Technology-Enabled AFib Management
- N/ACatheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
- —The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System
- —Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
- N/AThe Impact of Expandable Cryoballoon on Autonomic Control of the Heart
- N/ARESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
News(10)
- BMO most bullish on Merck's, bearish on BMS’ plans to contend with patent cliffsBMO Capital Markets is more impressed by Merck’s plans to replace lost Keytruda revenue than on Bristol Myers Squibb’s efforts to fill the expected void that will come from loss of exclusivity for…biospace · 2d ago
- ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plansADARx Pharmaceuticals has overshot its own IPO ambitions, as fellow RNA-focused biotech City Therapeutics also plans a public listing.fiercebiotech · 9d ago
- Newly formed Jaguar acquires Afib device assets from J&JJaguar LAA, a newly formed medtech, has acquired assets that are part of Johnson & Johnson’s AFib device Laminar program for an undisclosed price.fiercebiotech · 19d ago
- Abbott garners FDA nod for its TactiFlex catheter to treat AFibAbbot received FDA clearance for its latest-generation catheter that allows physicians more flexibility when treating atrial fibrillation in patients.fiercebiotech · 25d ago
- AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapiesADARx has reinvigorated its ambitions to go public as the AbbVie-backed biotech looks to fund ongoing clinical trials of a range of next-gen small interfering RNA medicines.fiercebiotech · 28d ago
- Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial failsBMS is barreling toward a clinical trial readout that an H.C. Wainwright analyst believes could contribute to the return of mergers between mega-cap drugmakers.biospace · 1mo ago
- Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ showsOxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study showing reduced dementia risk.stat · 1mo ago
- As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca mergerWhile both drugmakers face looming patent cliffs, analysts say joining forces could help Bristol Myers Squibb replenish its eroding portfolio—while the strategic case for AstraZeneca seems to be mo…biospace · 2mo ago
- BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delaysStrong quarterly results are prompting Bristol Myers Squibb to lift its 2026 outlook, though the company is facing another delay for key Cobenfy Alzheimer’s data and a pushed-back readout for milve…biospace · 2mo ago
- BMS CEO Boerner doesn’t ‘feel any compulsion to chase deals’ despite lack of M&A this yearBMS may have been absent from the dealmaking spree of some of its Big Pharma peers this year, but that might not change anytime soon.fiercebiotech · 2mo ago
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that